• PDF / 170,049 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 91 Downloads / 228 Views

DOWNLOAD

REPORT

867-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 28 Nov 2020 No. 867

1

Recommend Documents

Ferric carboxymaltose

154 1 166KB

Ferric-carboxymaltose

170 8 166KB

Ferric-carboxymaltose

170 55 167KB

Ferric carboxymaltose

170 34 166KB

Ferric-carboxymaltose

159 38 166KB

Ferric carboxymaltose for sub-acute and chronic iron deficiency anemia in inherited platelet function defects

160 2 465KB

Ferric carboxymaltose/monosodium phosphate

188 4 167KB

Bevacizumab preferred option in mCRC

196 73 111KB

Risk of hypophosphataemia with ferric carboxymaltose

160 39 166KB

Iron Deficiency in Cyanobacteria

201 83 12MB

NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic

162 20 998KB

Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Afri

151 17 735KB